All Posts By

Smartkarma Daily Briefs

Most Read: Li Auto, Socionext, HDFC Bank, Yachiyo Industry, Foxconn Industrial Internet, Tryt Inc, Mini Kospi 200 Futures and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Socionext Lock-Up – Up 2.67x Since IPO. US$930m Worth of Shares to Be Unlocked
  • Hang Seng Index Rebalance Preview: 80 Member Target Achieved; What Next?
  • Socionext (6526 JP) – Pre-IPO Lockup Expiry Offering Will Double Real World Float
  • HDFC/HDFC Bank Merger: Foreigners Sell HDFC; LTIM in NIFTY; JSP in NEXT50
  • Socionext Placement – A US$1.8bn Cleanup, Will Have to Give up Some of Its 6x Listing Gains
  • And Now For Something Truly Offensive – Honda Pays <0.5x Book for Yachiyo
  • SSE50 Index Rebalance Preview: Potential Adds Powering Higher
  • Socionext (6526 JP): US$1.9bn Secondary Placement
  • Tryt IPO – Valuation Seems Digestible at the Bottom End, but the Firm Still Needs to Get a Lot Right
  • Impact of Allowing Negotiated Block Trades for Eight Futures Spreads, Incl. SSF SP


Socionext Lock-Up – Up 2.67x Since IPO. US$930m Worth of Shares to Be Unlocked

By Clarence Chu

  • Socionext (6526 JP) was listed on 12th Oct 2022, when it raised US$457m in its upsized Japan IPO. Its six-month lockup will expire on 9th Apr 2023.
  • Socionext is a fabless semiconductor provider which commenced operations after integrating the system on a chip (SoC) businesses of Fujitsu Semiconductor Limited and Panasonic Holding Corporation in 2015.
  • Coming up for six-month lockup expiry are the Development Bank of Japan, Fujitsu and Panasonic, the trio had each trimmed their respective stakes in the IPO.

Hang Seng Index Rebalance Preview: 80 Member Target Achieved; What Next?

By Brian Freitas

  • We finally got to 80 Hang Seng Index constituents in June. Now comes the next step of moving up to 100 index constituents though there is no timeline for completion.
  • The conclusions of the market consultation on the inclusion of foreign stocks in the Hang Seng Index should be announced soon though implementation could start only in December.
  • We highlight 10 potential inclusions to the index with passive trading impact varying from 1.5-5.6 days of ADV. There are large shorts on some of the stocks.

Socionext (6526 JP) – Pre-IPO Lockup Expiry Offering Will Double Real World Float

By Travis Lundy

  • Today after the close, SoC and market darling Socionext (6526 JP) announced that DBJ, Fujitsu, and Panasonic would offer the remaining shares they in a US$1.8bn secondary offering.
  • Pshaw…. that’s only 2.5 days of 20-day ADV… Not a lot. But in fact, that is a LOT of stock. 
  • I harp on understanding shareholder structure. I think it worthwhile. Here it matters too.

HDFC/HDFC Bank Merger: Foreigners Sell HDFC; LTIM in NIFTY; JSP in NEXT50

By Brian Freitas


Socionext Placement – A US$1.8bn Cleanup, Will Have to Give up Some of Its 6x Listing Gains

By Sumeet Singh

  • Three shareholders of Socionext (6526 JP) aim to raise around US$1.8bn via selling all of their shares in Socionext.
  • Socionext was listed on 12th Oct 2022, when it raised US$457m in its upsized Japan IPO. Its six-month lockup expired in Apr 2023. Its shares are up 6x since listing.
  • In this note, we talk about the deal dynamics and run the deal through our ECM framework.

And Now For Something Truly Offensive – Honda Pays <0.5x Book for Yachiyo

By Travis Lundy

  • Every now and then, you get a tender offer proposal which is truly offensive. This is one. 
  • Yes, existing ICE-related autoparts makers are under the cosh as they face down obsolesence induced by competition from EVs. Fuel tank makers like Yachiyo are at risk. 
  • But this bid started at <0.3x book, and ended at <0.5x book, despite significant net financial assets and lots of unrecognised DTAs. 

SSE50 Index Rebalance Preview: Potential Adds Powering Higher

By Brian Freitas

  • Two thirds of the way through the review period, we see 10 potential adds/8 potential deletes in December. However, there can be a maximum of 5 changes at a review.
  • We estimate a one-way turnover of 5.8% at the December rebalance leading to a one-way trade of CNY 4.67bn. Index arb balances could increase the impact on the stocks.
  • The potential adds have outperformed the potential deletes over the last six months and there has been renewed outperformance over the last month.

Socionext (6526 JP): US$1.9bn Secondary Placement

By Arun George

  • Socionext (6526 JP) announced a pure secondary offering of 12.6 million or 37.50% of outstanding shares. At the last close, the placement is worth JPY277 billion (US$1.9 billion)
  • The selling shareholders’ primary motivation for exiting their shareholding is to capitalise on the extraordinary share price. Socionext shares are up 6x from the IPO price of JPY3,650 per share.
  • We think looking at recent large Japanese placements is instructive to understand the potential offer price. The pricing date will fall between 11 to 13 July (likely 11 July).

Tryt IPO – Valuation Seems Digestible at the Bottom End, but the Firm Still Needs to Get a Lot Right

By Clarence Chu

  • Tryt Inc (9164 JP) is looking to raise up to US$360m in its Japan IPO.
  • Tryt Inc (Tryt) offers employee placement services and temporary staffing services for the elderly care, nursing care and childcare workers segments.
  • In this note, we will revisit our earnings assumptions and share our thoughts on valuation at the final price range.

Impact of Allowing Negotiated Block Trades for Eight Futures Spreads, Incl. SSF SP

By Sanghyun Park

  • It is highly probable that SP trading will increase after July 31st, as this will provide a more conducive environment for the seamless rollover of large positions.
  • Considering the actual impact on the market, we may have to pay more attention to the potential surge in trading volume for single-stock futures SP.
  • We see a rise in aggressive position setups in event trading, including rights offerings. This may lead to a more substantial price impact by increasing the intensity of such trading.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief South Korea: PhilEnergy, Samsung Electronics, Fadu , Celltrion Inc and more

By | Daily Briefs, South Korea

In today’s briefing:

  • PhilEnergy IPO Bookbuilding Results Analysis
  • At the Core Lies Why Anything Named Samsung Deserves a Discount
  • Fadu IPO Valuation Analysis
  • Celltrion (068270 KS): Humira Biosimilar Launch in US; Filed New Biosimilar Marketing Application


PhilEnergy IPO Bookbuilding Results Analysis

By Douglas Kim

  • PhilEnergy’s IPO price has been determined a 34,000 won. The company will raise 95.6 billion won in this IPO offering. 
  • A total of 1,955 institutional investors participated in the IPO offering with a competition demand ratio of 1,812 to 1. 
  • Given the exceptional book building results, it is highly likely that PhilEnergy will have a strong price performance once it starts trading. 

At the Core Lies Why Anything Named Samsung Deserves a Discount

By Ken S. Kim


Fadu IPO Valuation Analysis

By Douglas Kim

  • Our base case valuation analysis suggests implied market cap of 2.2 trillion won or 43,676 won per share, representing 41% higher than the high end of the IPO price range. 
  • At the high end of our valuation sensitivity analysis, it suggests implied price of 62,893 won per share, representing 103% higher than the high end of the IPO price range.
  • Fadu is a system semiconductor fabless company specializing in data centers, which is experiencing a strong growth due to higher data demand for cloud, AI/Big data, 5G, and autonomous driving.

Celltrion (068270 KS): Humira Biosimilar Launch in US; Filed New Biosimilar Marketing Application

By Tina Banerjee

  • Celltrion Inc (068270 KS) has launched Humira biosimilar Yuflyma in the U.S. market, with a list price of $6,576.50 per month, 5% cheaper than Humira.
  • Yuflyma is a citrate-free formulation that is highly concentrated. More than 80% of patients treated with Humira in the U.S. rely on a high-concentration and citrate-free formulation.
  • Celltrion has submitted marketing application to the FDA for Eylea biosimilar candidate, CT-P42. The company plans to file for approval for the same in Europe and other countries later.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Indonesia: ABM Investama, J&T Global Express and more

By | Daily Briefs, Indonesia

In today’s briefing:

  • Asia HY Monthly – June 2023 – Lucror Analytics
  • J&T Global Express Pre-IPO, Part 2: SE Asia Operation | Demand, Supply Profiles | Valuation Approach


Asia HY Monthly – June 2023 – Lucror Analytics

By Charles Macgregor

The Asia Monthly focuses on providing updates on recent events, information on new issues and spread movements, as well as summarising our top picks. The Asia Monthly is intended to broaden investors’ understanding of the Asian USD high-yield market.


J&T Global Express Pre-IPO, Part 2: SE Asia Operation | Demand, Supply Profiles | Valuation Approach

By Daniel Hellberg

  • In this insight, we examine J&T Global Express (1936374D CH)‘s operation in SE Asia, where it’s the region’s dominant player, with market share of 22.5% by volume 
  • We profile SE Asian demand and supply and compare these to the development of China’s express industry, acknowledging the key role Alibaba (ADR) (BABA US) has played there
  • We also present a framework for estimating the value of J&T’s SE Asian operation by identifying the most appropriate comps and EV valuation multiples

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Energy Absolute and more

By | Daily Briefs, Thailand

In today’s briefing:

  • ASEAN EV Ecosystem Series: Committed Towards Building a Regional EV Ecosystem


ASEAN EV Ecosystem Series: Committed Towards Building a Regional EV Ecosystem

By Shifara Samsudeen, ACMA, CGMA

  • EV adoption in the ASEAN is very low compared to developed markets including the US, the Europe and China due to higher ASPs and lack of logistics, maintenance and repair.
  • However, there has been a rapid growth in EV related investment in the region recently, focusing on developing domestic EV markets to make them more affordable while conserving the environment.
  • The governments have put forward several incentives such as government funding, tax incentives to buy EVs, while introducing measures to discourage the use of ICE vehicles.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: IAC/InterActiveCorp, Brown Forman Corp Class B, Cintas Corp, Eastman Chemical Co, Hologic Inc and more

By | Daily Briefs, United States

In today’s briefing:

  • IAC Inc.: 4 Ways In Which This Company Is Shaping Its Long-Term Growth Prospects! – Key Drivers
  • Brown-Forman Corporation: How Resilience
  • Cintas Corporation: 4 Reasons Why Cintas is Leading the Way in Uniform Rental and Safety Services! – Financial Forecasts
  • Eastman Chemical Company: Unlocking Its Growth Potential With A Unique Strategic Approach! – Key Drivers
  • Hologic Inc.: 3 Key Drivers & Strategic Priorities Driving Growth – Financial Forecasts


IAC Inc.: 4 Ways In Which This Company Is Shaping Its Long-Term Growth Prospects! – Key Drivers

By Baptista Research

  • IAC managed to exceed analyst expectations in terms of revenue as well as earnings.
  • The company’s emphasis on core fundamentals and operational efficiency has yielded profitability and improved customer experiences.
  • IAC is also focused on driving revenue growth through investments in customer experience and strategic revenue reallocation.

Brown-Forman Corporation: How Resilience

By Baptista Research

  • Brown-Forman managed to surpass the revenue expectations and the earnings expectations of Wall Street.
  • With an increase in reported net sales, driven by organic growth and favorable price/mix, Brown-Forman demonstrated its ability to navigate challenges and capitalize on consumer demand.
  • Brands like Jack Daniel’s Tennessee Whiskey and Woodford Reserve were standout performers, showing organic net sales growth and capturing consumer attention through innovative campaigns and partnerships.

Cintas Corporation: 4 Reasons Why Cintas is Leading the Way in Uniform Rental and Safety Services! – Financial Forecasts

By Baptista Research

  • Cintas managed to exceed analyst expectations in terms of revenue as well as earnings.
  • The Uniform Rental and Facility Services segment experienced solid organic growth driven by increased volume and new customer acquisitions.
  • The company’s First Aid and Safety Services segment revenue grew 16.4% organically, driven by strong demand for first aid products and services, as well as training and compliance solutions whereas its All Other segment revenue grew 14.7% organically, driven by growth in fire protection services and direct sale uniform businesses.

Eastman Chemical Company: Unlocking Its Growth Potential With A Unique Strategic Approach! – Key Drivers

By Baptista Research

  • Eastman delivered a mixed result in the recent quarter, with revenues below market expectations, but it managed to surpass the analyst consensus in terms of earnings.
  • The company made improvements in the Fiber business due to increased prices and operational performance.
  • Supply-side factors, such as capacity reduction and effective capacity loss, have created tight markets and a focus on the security of supply.

Hologic Inc.: 3 Key Drivers & Strategic Priorities Driving Growth – Financial Forecasts

By Baptista Research

  • Hologic managed to exceed the revenue expectations as well as the earnings expectations of Wall Street.
  • The company’s financial results surpassed expectations, driven by robust organic revenue growth in key divisions like Diagnostics, Surgical, and Breast Health excluding COVID-19, driven by new products, market expansion and customer loyalty.
  • Hologic’s COVID-19 assay revenue was $233 million, down 47% sequentially, reflecting lower testing demand and increased competition.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: HT Media Ltd and more

By | Daily Briefs, Singapore

In today’s briefing:

  • 10 in 10 with NoonTalk Media – Going Regional


10 in 10 with NoonTalk Media – Going Regional

By Geoff Howie

10 in 10 with NoonTalk Media – Going Regional

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Australia: Costa Group Holdings, Suncorp and more

By | Australia, Daily Briefs

In today’s briefing:

  • Costa Group (CGC AU): Paine Schwartz’s Indicative Proposal
  • Suncorp – Decision on ANZ Takeover In Weeks, Competition Can Worsen If Allowed


Costa Group (CGC AU): Paine Schwartz’s Indicative Proposal

By Arun George

  • Costa Group Holdings (CGC AU)  has disclosed an indicative non-binding proposal from Paine Schwartz Partners at A$3.50 per share (A$3.54 including potential interim dividend).
  • The Board has granted eight weeks of non-exclusive due diligence. The due diligence, which started on 6 June, ends on 1 August.
  • The offer price is attractive compared to peer multiples and historical trading ranges. At the current price of A$3.35, the gross spread is 4.5% (5.7% including dividend).

Suncorp – Decision on ANZ Takeover In Weeks, Competition Can Worsen If Allowed

By Daniel Tabbush

  • One of main criteria for ACCC to allow ANZ’s takeover of Suncorp centers around competition, will it worsen as a result
  • There are 8 banks in Australia with over 100 branches, if the takeover is allowed, this puts the 127 Suncorp branches into the 668 branch stable of ANZ
  • There is plenty of expert and public testimony that such a merger would see less competition especially in SME and agribusiness loans, and possibly limit physical access to banking

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: HDFC Bank, Bajaj Finance Ltd, HDFC Limited, ABM Investama and more

By | Daily Briefs, India

In today’s briefing:

  • HDFC/HDFC Bank Merger: Foreigners Sell HDFC; LTIM in NIFTY; JSP in NEXT50
  • Bajaj Finance: Q1FY24 Interim Update – Stellar Growth Continues
  • Quiddity Leaderboard BSE/​​​SENSEX Dec 23: HDFC Intra-Review Replacements & Other Expected Changes
  • Asia HY Monthly – June 2023 – Lucror Analytics


HDFC/HDFC Bank Merger: Foreigners Sell HDFC; LTIM in NIFTY; JSP in NEXT50

By Brian Freitas


Bajaj Finance: Q1FY24 Interim Update – Stellar Growth Continues

By Ankit Agrawal, CFA

  • Q1FY24 AUM growth came in stellar at 9%+ QoQ, led by highest-ever quarterly AUM addition of INR 22700cr vs INR 16537cr QoQ. 
  • BAF recorded its highest-ever quarterly increase in customer franchise at 3.84mm, taking the total to 72.98mm vs 69.14mm QoQ. New loans booked were also strong at 9.94mm vs 7.56mm QoQ.
  • Deposits book grew strong to INR 49,900cr vs INR 44,666cr, a growth of 11.7%+ QoQ. Liquidity surplus is at INR 12,700cr vs INR 11,852cr QoQ.

Quiddity Leaderboard BSE/​​​SENSEX Dec 23: HDFC Intra-Review Replacements & Other Expected Changes

By Janaghan Jeyakumar, CFA

  • In this insight, we take a look at the Potential ADDs/DELs for the BSE SENSEX, 100, and 200 Indices in the December 2023 Rebalance.
  • The HDFC/HDFC Bank Merger is expected to trigger index changes in the next few days and we take a look at our expectations for these intra-review changes.
  • Apart from that, I see no other changes for SENSEX in December 2023. However, there could be up to six changes for both BSE 100 and BSE 200.

Asia HY Monthly – June 2023 – Lucror Analytics

By Charles Macgregor

The Asia Monthly focuses on providing updates on recent events, information on new issues and spread movements, as well as summarising our top picks. The Asia Monthly is intended to broaden investors’ understanding of the Asian USD high-yield market.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: ARTERIA Networks Corp, Toyo Construction, Rakuten Group , Kao Corp, Yachiyo Industry, Nikkei 225, Tryt Inc and more

By | Daily Briefs, Japan

In today’s briefing:

  • Arteria Networks (4423) Tender Launches 5 July.
  • Toyo Construction (1890) Plans Governance Review, Promises Neutrality on a YFO TOB Proposal Decision
  • Rakuten: An Attractive Value Opportunity After 80% Value Decline in 8 Years
  • Kao (4452) | Is It Time to Buy This Dividend Aristocrat?
  • Yachiyo Industry (7298 JP): Honda’s Pre-Conditional Tender Offer
  • EQD | Nikkei 225 (NKY) WEEKLY Rising but May Encounter Short-Term Resistance
  • TRYT IPO: Margins on a Downward Trend


Arteria Networks (4423) Tender Launches 5 July.

By Travis Lundy


Toyo Construction (1890) Plans Governance Review, Promises Neutrality on a YFO TOB Proposal Decision

By Travis Lundy

  • The Nikkei has an article today with details of an interview with new Toyo Construction (1890 JP) Chairman Yoshida and President Obayashi. There will be a 2-3 month governance review.
  • It will review decision-making process, “profit management” (利益管理), and business investment decisions (事業への投資判断).  Chairman Yoshida had a quote on neutrality on a YFO proposal. My wording there was carefully chosen.
  • The President also said they expect ongoing synergies with Infroneer, and will maintain MTMP/Mitsui OSK Partnership management plans. Their words were chosen carefully too. 

Rakuten: An Attractive Value Opportunity After 80% Value Decline in 8 Years

By Oshadhi Kumarasiri

  • Rakuten Group (4755 JP), having experienced an 80% decline in value over the last 8 years, now emerges as an enticing prospect for value investors.
  • The combined fair value of Rakuten’s Cards, Bank, and Mobile businesses now surpasses 100% of the company’s market capitalization.
  • Rakuten Ichiba, valued at ¥600bn, appears significantly undervalued when compared to ZOZO Inc (3092 JP) and MonotaRO Co Ltd (3064 JP), which hold approximately 2.0x Rakuten Ichiba’s valuation.

Kao (4452) | Is It Time to Buy This Dividend Aristocrat?

By Mark Chadwick

  • Kao has the lonest period of consecutive earnings growth in the Nikkei’s new “Consecutive Dividend Growth Stock Index”
  • With a 2.8% yield and a long history of raising its dividend, Kao should definitely be on the income investor’s radar screen
  • Despite the recent underperformance of the stock (-4% ytd), Kao does not represent compelling valuations

Yachiyo Industry (7298 JP): Honda’s Pre-Conditional Tender Offer

By Arun George

  • Yachiyo Industry (7298 JP) has recommended Honda Motor (7267 JP)’s pre-conditional tender offer of JPY1,390 per share, a 17.5% premium to the undisturbed price.
  • Post-Completion, Honda will transfer a 81% stake to Samvardhana Motherson Automotive Systems Group BV. The pre-conditions relate to various country approvals (China, the US, Brazil, and India).
  • The offer is expected to open in October. Achieving the 66.67% minimum ownership ratio requires a 32.6% minority acceptance rate which is doable as the offer is reasonable.   

EQD | Nikkei 225 (NKY) WEEKLY Rising but May Encounter Short-Term Resistance

By Nico Rosti

  • Good probability of reversal (>60%) for the Nikkei 225 (NKY INDEX)if closing this week up and/or if market price reaches => 34033 intra-week (better: => 34255).
  • Index can go a bit higher but first will probably consolidate/digest the latest rally from April. Expect non-directionality. If WEEKLY rally lasts =>3 weeks, place high-probability SHORT trade.
  • A pullbackbelow 33189.04 (last WEEKLY Close) seems unlikely this week. In case, buy-the-dips until the price reaches 32586 (Q2 barrier). Past that point the market could sink <= 31750.

TRYT IPO: Margins on a Downward Trend

By Shifara Samsudeen, ACMA, CGMA

  • TRYT Group is engaged in job placement and temporary staffing in the medical and welfare fields. The company has filed for an IPO and plans to raise around $450m.
  • The company’s top line has continued to expand; however, margins have continued to narrow down over the last 3-4 years.
  • We remain concerned over the company’s growth prospects and would only recommend subscribing if the IPO is priced attractively.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Li Auto, Perfect Medical Health, Shenzhou Intl Group Holdings, Hainan Meilan International Airport, Fenbi Ltd, ABM Investama, Silver Dragon Water Supply Group, PDD Holdings Inc, Country Garden Holdings Co and more

By | China, Daily Briefs

In today’s briefing:

  • Hang Seng Index Rebalance Preview: 80 Member Target Achieved; What Next?
  • Perfect Medical Management FY23 Concall: Highlights Bright Outlook for FY24, Aggressive Expansion
  • Shenzhou (2313 HK): Contract Mfr for Leading Sportswear Brands Facing Challenging Demand Outlook.
  • Hainan Meilan’s (357 HK)’s Arbitration Case Is Not Without Merit
  • Fenbi (2469 HK): Rightfully Sold, Wrongfully Punished
  • Asia HY Monthly – June 2023 – Lucror Analytics
  • Silver Dragon Water Supply Group Pre-IPO Tearsheet
  • [PDD (PDD US, BUY, TP US$88) TP Change]: Facing Stiff China Competition and Rising Temu Costs
  • Morning Views Asia: Country Garden Holdings Co, First Pacific Co
  • Morning Views Asia: Country Garden Holdings Co, First Pacific Co


Hang Seng Index Rebalance Preview: 80 Member Target Achieved; What Next?

By Brian Freitas

  • We finally got to 80 Hang Seng Index constituents in June. Now comes the next step of moving up to 100 index constituents though there is no timeline for completion.
  • The conclusions of the market consultation on the inclusion of foreign stocks in the Hang Seng Index should be announced soon though implementation could start only in December.
  • We highlight 10 potential inclusions to the index with passive trading impact varying from 1.5-5.6 days of ADV. There are large shorts on some of the stocks.

Perfect Medical Management FY23 Concall: Highlights Bright Outlook for FY24, Aggressive Expansion

By Sameer Taneja

  • We spoke with the management of Perfect Medical Health (1830 HK). The key highlight is a steady recovery for FY24e and an overall expansion of 60% in three years. 
  • Expansion plans in HK (75% of revenue) have commenced, with ten centers opening over the year, adding to the existing 22 HK centers (one already opened in June 2023).
  • They also highlighted an aggressive long-term goal of making one bn HKD of profit by FY26 (Mkt cap: 4.8 bn HKD) and short-term guidance of 30-40% profit growth for FY24e. 

Shenzhou (2313 HK): Contract Mfr for Leading Sportswear Brands Facing Challenging Demand Outlook.

By Robert C Prather Jr

  • Key customers & their retail partners battling excess inventory, waning consumer demand, and market share losses in certain geographies
  • Plans for capacity expansion amid demand uncertainties and alt data and macro picture may prove aggressive and along with risks of reshoring/nearshoring & friend-shoring may prove margin dilutive
  • Consensus expectations for 2H23 and 2024 appear overly optimistic and valuation is not cheap given the growth profile

Hainan Meilan’s (357 HK)’s Arbitration Case Is Not Without Merit

By David Blennerhassett

  • Back On 29 September 2019, Hainan Meilan International Airport (357 HK) entered into a subscription agreement with Hopu-affiliate Aero Infrastructure, for 200mn new H shares at HK$4.69/share.
  • That issuance failed as CSRC approval was not secured by the Long Stop. Hopu reckoned HMIA reneged on its duties to secure approval and lodged a notice of arbitration.
  • HKIAC recently agreed and opines HMIA did not use its best endeavours to complete the subscription. Hopu is seeking up to HK$6.962bn in compensation. Quite the overhang.

Fenbi (2469 HK): Rightfully Sold, Wrongfully Punished

By Steve Zhou, CFA

  • Fenbi Ltd (2469 HK) is a newly listed China edtech company that focuses on tutoring for China civil servant exams.  
  • The company’s share price was caught by a perfect storm in June, dropping by as much as 70% during the month.
  • Very interesting opportunity to have exposure to a quality company in a sector that is very different from K12 tutoring.  

Asia HY Monthly – June 2023 – Lucror Analytics

By Charles Macgregor

The Asia Monthly focuses on providing updates on recent events, information on new issues and spread movements, as well as summarising our top picks. The Asia Monthly is intended to broaden investors’ understanding of the Asian USD high-yield market.


Silver Dragon Water Supply Group Pre-IPO Tearsheet

By Clarence Chu

  • Silver Dragon Water Supply Group (2210081D CH) is looking to raise at least US$100m in its upcoming Hong Kong IPO. The bookrunners on the deal are HSBC and Huatai International.
  • Silver Dragon Water Supply Group (SDW) is principally engaged in the supply of tap water, raw water and pipeline direct drinking water in China.
  • As per Frost & Sullivan (F&S), the firm had the largest water pipeline network in terms of water pipeline length among all water supply companies in China in 2022.

[PDD (PDD US, BUY, TP US$88) TP Change]: Facing Stiff China Competition and Rising Temu Costs

By Shawn Yang

  • We expect PDD to report 1Q23’s revenue and non-GAAP net income (5.4%) and (5.6%) vs. consensus, respectively.
  • Taobao/Tmall and JD launched more subsidy campaigns in 2Q23 to strengthen their low-cost mindsets among customers, while PDD remains to be more restrained, which might lead to decelerating top-line growth.
  • We cut PDD’s FY23 EPS by 3.7% and TP to US$ 88 on slower 2Q23 top-line growth and increasing Temu costs, but maintain its BUY rating.

Morning Views Asia: Country Garden Holdings Co, First Pacific Co

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Morning Views Asia: Country Garden Holdings Co, First Pacific Co

By Charles Macgregor

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars